FILTER RECORDS BY
De Quervain JF (1930)
Zusammenfassung der Ergebnisse der schweizerischen Sammelstatistik über Brustkrebs von 1911-1915. [Summary of the results of the aggregated Swiss hospital statistics on breast cancer from 1911-1915]. Bern-Berlin: Huber.
View
Goodman LS, Wintrobe MM, Dameshek W, Goodman MJ, Gilman A and McLennan MT (1946)
Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. Journal of the American Medical Association 132:126-132.
View
Farber S, Diamond LK, Mercer RD, Sylvester RF, Wolff JA (1948)
Temporary remissions in acute leukaemia in children produced by folic acide antagonist, 4-aminopteroyl-glutamic acid (aminopterin). New England Journal of Medicine 238:787-793.
View
Merk R (1948)
Die Stickstoffsenfgasbehandlung der Lymphogranulomatose [Nitrogen Mustard Treatment of Lymphogranulomatosis]. Medizinische Klinik 43:629-35.
View
Witts LJ (1959)
Medical surveys and clinical trials: some methods and applications of group research in medicine. Oxford: Oxford University Press.
View
Zubrod CG, Schneiderman M, Frei E, Brindley C, Gold GL, Shnider B, Oviedo R, Gorman J, Jones R, Jonsson U, Colsky J, Chalmers T, Ferguson B, Dederick M, Holland J, Selawry O, Regelson W, Lasagna L, Owens AH (1960)
Appraisal of methods for the study of chemotherapy in man: Comparative therapeutic trial of nitrogen mustard and thiophosphoramide. Journal of Chronic Diseases 11:7-33.
View
Bross ID (1966)
Spurious effects from an extraneous variable. Journal of Chronic Diseases 19:637-47.
View
Schneiderman MA (1966)
Therapeutic trials in cancer. Working paper prepared for WHO Expert Committee on Cancer Treatment, Geneva, Switzerland, 9-15 March 1965. WHO/CANC/66.66.
View
Stjernswärd J (1974)
Decreased survival related to irradiation postoperatively in early breast cancer. Lancet 304:1285-1286.
View
Levitt SH, McHugh RB, Song CW (1976)
Radiotheraphy in the postoperative treatment of operable cancer of the breast. Part II. A re-examination of Stjernsward’s application of the Mantel-Haenszel statistical method. Evaluation of the effect of the radiation on immune response and suggestions for postoperative radiotherapy. Cancer 39:933-940.
View
Pocock SJ (1977)
Randomised clinical trials. BMJ 1:1661.
View
Colombo F, Shapiro S, Slone D, Tognoni G (1977)
Epidemiological evaluation of drugs. Amsterdam: Elsevier/North-Holland Biomedical Press.
View
Foon KA, Smalley RV, Riggs CW, Gale RP (1983)
The role of immunotherapy in acute myelogenous leukemia. Arch Intern Med 143: 1726-1731
View
Roberts MM, Alexander FE, Anderson TJ, Forrest APM, Hepburn W, Huggins A, Kirkpatrick AE, Lamb J, Lutz W, Muir BB (1984)
The Edinburgh randomised trial of screening for breast cancer: Description of method. British Journal of Cancer 50:1-6.
View
Tabár L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Gröntoft O, Ljungquist U, Lundström B, Månson JC, Eklund G, Day NE, Pettersson F (1985)
Reduction in mortality from breast cancer after mass screening with mammography Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 13;1:829-32.
View
Himel HN, Liberati A, Gelber RD, Chalmers TC (1986)
Adjuvant chemotherapy for breast cancer: A pooled estimate based on results from published randomized control trials. JAMA 256:1148-1159.
View
Peto J, Eden OB, Lilleyman J, Richards S (1986)
Improvement in treatments for children with acute lymphoblastic leukaemia: The Medical Research Council UKALL Trials, 1972-84. Lancet 1:408-411.
View
Simes RJ (1986)
Publication bias: the case for an international registry of clinical trials. Journal of Clinical Oncology 4:1529-41.
View
Mayer JA, Dubbert PM, Scott RR, Dawson BL, Ekstrand ML, Fondren TG (1987)
Breast self-examination: The effects of personalized prompts on practice frequency. Behavior Therapy 18:135-46.
View
Yusuf S, Simon R, Ellenberg SS (1987)
Proceedings of the workshop on methodologic issues in overviews of randomized clinical trials, May 1986. Statistics in Medicine 6:217-409.
View
Early Breast Cancer Trialists' Collaborative Group (1988)
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. New England Journal of Medicine 319:1681-92.
View
Early Breast Cancer Trialists' Collaborative Group (1990)
Treatment of early breast cancer. Vol 1. Worldwide evidence, 1985-1990. Oxford: Oxford University Press.
View
Worden JK, Solomon LJ, Flynn BS, Costanza MC, Foster RS, Dorwaldt AL, Weaver SO (1990)
A community-wide program in breast self-examination training and maintenance. Preventive Medicine 19;254-269.
View
Advanced Ovarian Cancer Trialists Group (1991)
Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. BMJ 303:884-893.
View
Gray R, Wheatley K (1991)
How to avoid bias when comparing bone marrow transplantation with chemotherapy. Proceedings of the International Course on Bone Marrow Transplantation in Children, 28 Nov-1 Dec 1990, Erice, Italy. Bone Marrow Transplantation 7, Suppl 3:9-12.
View
Rimer BK, Resch N, King E, Ross E, Lerman C, Boyce A, Engstrom PF (1992)
Multistrategy health education program to increase mammography use among women ages 65 and older. Public Health Reports 107:369-380.
View
Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, Kuderer NM, Lyman GH (2000)
The uncertainty principle and industry-sponsored research. Lancet 356:635-638.
View
Djulbegovic B, Kumar A, Soares HP, Hozo I, Bepler G, Clarke M, Bennett CL (2008)
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the national cancer institute-sponsored cooperative oncology groups, 1955 to 2006. Archives of Internal Medicine. 168:632-42.
View
Trotta F, Apolone G, Garattini S, Tafuri G (2008)
Stopping a trial early in oncology: for patients or for industry? Annals of Oncology Feb 29; doi:10.1093/annonc/mdn042.
View
Show
Armitage P† (2003).
Some recollections of the early years of the Medical Research Council (MRC) Statistical Research Unit. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Stjernswärd J (2009)
Meta-analysis as a manifestation of ‘bondförnuft’ (‘peasant sense’). JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Tröhler U (2010).
Johann Friedrich de Quervain (1868-1940). Swiss surgical innovator. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Spain P, Kadan-Lottick N (2010).
Observations of unprecedented remissions following novel treatment for acute leukemia in children in 1948. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Stjernswärd J (2013)
Personal reflections on contributions to pain relief, palliative care and global cancer control JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Peto J (2016).
Reflections on the importance of strict adherence to treatment protocols: acute lymphoblastic leukaemia in children in the 1970s in the US and the UK. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Peto R (2016).
Reflections on the design and analysis of clinical trials and meta-analyses in the 1970s and 1980s. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Zwarenstein M (2016).
‘Pragmatic’ and ‘Explanatory’ attitudes to randomized trials. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Jefferson T (2019).
Sponsorship bias in clinical trials – growing menace or dawning realisation? JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Nothing found, please try resetting your search filters